Alterations in the FFA profile of patients with GDM can also affect maternal physiology by altering the levels of FFA transporters, such as increased levels of plasma FA binding protein-4 (FABP4) and other proteins in the serum [96]. Here, FABP4 is linked to gestational diabetes.